Stay updated on GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.

Latest updates to the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe clinical trial record for GB1275 is now displayed, with its study design, eligibility criteria, outcomes, and locations. The record states that the trial was terminated and that no clear benefit was observed.SummaryDifference84%

- Check14 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice was added announcing NIH’s transition from the term “artificial intelligence” to “super intelligence” and linking to transition updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check56 days agoChange DetectedA 403 Forbidden error page is now shown, replacing the study record content with the site chrome. This indicates access to the page is blocked rather than a content update to the study record.SummaryDifference22%

Stay in the know with updates to GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.